No Data
Matinas MTNB Negotiations Terminated; Biofrontera BFRI Phase 3 Data
Biofrontera Shares Are Trading Higher After the Company Announced Top-line Results in Its Phase 3 Study of the Use of Ameluz With the BF-RhodoLED Lamp in the Treatment of SBCC.
Biofrontera Shares Halted On Circuit Breaker To The Upside, Stock Now Up 6.01%
Express News | Biofrontera Inc: Primary and Secondary Endpoints All Highly Statistically Significant
Express News | Biofrontera Inc - Ameluz-Pdt Achieved 65.5% Success Compared to 4.8% With Placebo
Rosalind Advisors, Inc. Reduces Stake in Biofrontera Inc
No Data
No Data
Money_Pit_Bull : you say it buddy